Ulf Dittmer Selected Research

Virus Diseases (Viral Diseases)

1/2022	HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.
1/2022	Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
10/2021	Metabolic requirements of NK cells during the acute response against retroviral infection.
1/2021	Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection.
1/2021	A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
1/2020	Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.
1/2020	A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds.
3/2019	Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance.
1/2019	Corrigendum to "Antibody-based immunotherapy of acyclovir resistant ocular herpes simplex virus infection" [Virology 512 (2017) 194-200].
1/2019	The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8+ T Cells During an Acute Retroviral Infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulf Dittmer Research Topics

Disease

109	Infections 01/2022 - 06/2001
40	Virus Diseases (Viral Diseases) 01/2022 - 06/2001
23	COVID-19 01/2022 - 01/2020
16	Retroviridae Infections (Infection, Retrovirus) 01/2021 - 03/2002
12	Neoplasms (Cancer) 01/2021 - 10/2003
11	Chronic Hepatitis B 11/2021 - 01/2013
11	Persistent Infection 01/2021 - 06/2001
10	HIV Infections (HIV Infection) 01/2020 - 10/2011
6	Coinfection 01/2022 - 11/2012
5	Viremia 01/2022 - 01/2003
5	Leukemia 11/2010 - 11/2002
3	Hepatitis B 01/2022 - 01/2021
3	Inflammation (Inflammations) 12/2020 - 11/2017
3	Disease Progression 11/2020 - 10/2003
3	Blindness (Hysterical Blindness) 01/2019 - 01/2015
3	Communicable Diseases (Infectious Diseases) 01/2013 - 10/2003
2	Chronic Renal Insufficiency 09/2021 - 01/2021
2	Epstein-Barr Virus Infections 11/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2020
2	Herpetic Keratitis 01/2019 - 12/2017
2	Acute Retinal Necrosis Syndrome 12/2017 - 01/2017
2	Splenomegaly 05/2016 - 01/2013
1	Breakthrough Infections 01/2022
1	COVID-19 breakthrough infections 01/2022
1	Rabies (Hydrophobia) 01/2022
1	Viral Encephalitis 12/2021
1	Iron Deficiencies 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 07/2021

Drug/Important Bio-Agent (IBA)

44	Antiviral Agents (Antivirals)IBA 01/2022 - 11/2002
22	VaccinesIBA 01/2022 - 06/2001
17	AntibodiesIBA 01/2022 - 08/2004
17	CytokinesIBA 05/2020 - 06/2001
15	InterferonsIBA 01/2022 - 10/2011
13	AntigensIBA 01/2022 - 07/2004
13	Interferon Type IIBA 01/2022 - 04/2006
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2007
10	Immunoglobulin G (IgG)IBA 01/2022 - 12/2016
10	LigandsIBA 01/2018 - 03/2010
9	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2013
9	Neutralizing AntibodiesIBA 01/2022 - 08/2004
8	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 01/2016
7	Messenger RNA (mRNA)IBA 01/2022 - 01/2003
7	Granzymes (Granzyme)IBA 01/2020 - 12/2004
6	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018 - 12/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
5	Interferon-alpha (Interferon Alfa)IBA 01/2022 - 01/2012
5	Complement System Proteins (Complement)IBA 01/2019 - 04/2010
5	OligodeoxyribonucleotidesIBA 04/2007 - 11/2002
4	Hepatitis B e AntigensIBA 01/2022 - 01/2020
4	PerforinIBA 01/2020 - 01/2003
4	Monoclonal AntibodiesIBA 01/2019 - 02/2011
4	Glycoproteins (Glycoprotein)IBA 01/2019 - 01/2015
4	Interleukin-6 (Interleukin 6)IBA 05/2015 - 06/2001
4	CPG-oligonucleotideIBA 05/2004 - 11/2002
3	PolymersIBA 01/2022 - 01/2021
3	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2020
3	Alanine Transaminase (SGPT)IBA 01/2022 - 11/2021
3	Nucleic AcidsIBA 01/2022 - 01/2021
3	Immunoglobulin M (IgM)IBA 01/2021 - 11/2017
3	InterleukinsIBA 01/2020 - 10/2011
3	Interleukin-2 (IL2)IBA 01/2020 - 02/2013
3	Viral AntigensIBA 01/2019 - 09/2011
3	Acyclovir (Aciclovir)FDA LinkGeneric 01/2019 - 01/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017 - 03/2010
3	Pharmaceutical PreparationsIBA 12/2017 - 04/2013
3	Interleukin-15 (Interleukin 15)IBA 11/2017 - 11/2016
3	Interleukin-12 (IL 12)IBA 01/2017 - 01/2003
2	Biological ProductsIBA 01/2022 - 01/2009
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2020
2	Tenofovir (Viread)FDA Link 11/2021 - 01/2020
2	Antigen-Antibody Complex (Immune Complex)IBA 11/2021 - 01/2021
2	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 11/2021 - 01/2020
2	Amino Acids FDA Link 10/2021 - 11/2012
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2021
2	Interferon-betaIBA 01/2021 - 03/2010
2	Interleukin-7 (Interleukin 7)IBA 01/2020 - 10/2011
2	Immune Checkpoint InhibitorsIBA 01/2020 - 11/2017
2	Viral DNAIBA 12/2019 - 01/2018
2	CEACAM1 ProteinIBA 01/2018 - 02/2015
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 06/2001
2	Interferon-gamma (Interferon, gamma)IBA 12/2017 - 03/2002
2	Interleukin-18 (Interleukin 18)IBA 11/2017 - 11/2016
2	Fas Ligand Protein (Fas Ligand)IBA 10/2017 - 12/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017 - 04/2008
2	Peptides (Polypeptides)IBA 01/2016 - 07/2007
2	Surface Antigens (Surface Antigen)IBA 01/2016 - 07/2007
2	Interleukin-5 (Interleukin 5)IBA 01/2013 - 06/2001
2	EpitopesIBA 11/2012 - 08/2007
2	DNA VaccinesIBA 12/2008 - 08/2007
1	AutoantibodiesIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Large Neutral Amino Acid-Transporter 1IBA 10/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 10/2021
1	IronIBA 10/2021

Therapy/Procedure

26	Therapeutics 01/2022 - 10/2003
17	Immunotherapy 01/2021 - 03/2004
2	Critical Care (Surgical Intensive Care) 01/2021 - 12/2020
2	Kidney Transplantation 11/2020 - 11/2020
2	Transplantation 02/2018 - 12/2013
1	Liver Transplantation 07/2021